Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 126

1.

Polymorphisms in genes related to inflammation, NSAID use, and the risk of prostate cancer among Danish men.

Kopp TI, Friis S, Christensen J, Tjønneland A, Vogel U.

Cancer Genet. 2013 Jul-Aug;206(7-8):266-78. doi: 10.1016/j.cancergen.2013.06.001. Epub 2013 Jul 20.

PMID:
23880210
2.

Polymorphisms in the xenobiotic transporter Multidrug Resistance 1 (MDR1) and interaction with meat intake in relation to risk of colorectal cancer in a Danish prospective case-cohort study.

Andersen V, Ostergaard M, Christensen J, Overvad K, Tjønneland A, Vogel U.

BMC Cancer. 2009 Nov 21;9:407. doi: 10.1186/1471-2407-9-407.

3.

Polymorphisms in genes involved in the inflammatory response and interaction with NSAID use or smoking in relation to lung cancer risk in a prospective study.

Vogel U, Christensen J, Wallin H, Friis S, Nexø BA, Raaschou-Nielsen O, Overvad K, Tjønneland A.

Mutat Res. 2008 Mar 1;639(1-2):89-100. doi: 10.1016/j.mrfmmm.2007.11.004. Epub 2007 Nov 26.

PMID:
18164040
4.

Genetic polymorphisms and the cardiovascular risk of non-steroidal anti-inflammatory drugs.

St Germaine CG, Bogaty P, Boyer L, Hanley J, Engert JC, Brophy JM.

Am J Cardiol. 2010 Jun 15;105(12):1740-5. doi: 10.1016/j.amjcard.2010.01.352.

PMID:
20538124
5.

Inflammation-related gene polymorphisms and colorectal adenoma.

Gunter MJ, Canzian F, Landi S, Chanock SJ, Sinha R, Rothman N.

Cancer Epidemiol Biomarkers Prev. 2006 Jun;15(6):1126-31.

6.

Polymorphisms in COX-2, NSAID use and risk of basal cell carcinoma in a prospective study of Danes.

Vogel U, Christensen J, Wallin H, Friis S, Nexø BA, Tjønneland A.

Mutat Res. 2007 Apr 1;617(1-2):138-46. Epub 2007 Jan 20.

PMID:
17307204
7.

Peroxisome proliferator-activated [corrected] receptor-gamma2 [corrected] Pro12Ala, interaction with alcohol intake and NSAID use, in relation to risk of breast cancer in a prospective study of Danes.

Vogel U, Christensen J, Nexø BA, Wallin H, Friis S, Tjønneland A.

Carcinogenesis. 2007 Feb;28(2):427-34. Epub 2006 Sep 6. Erratum in: Carcinogenesis. 2007 Sep;28(9):2062.

PMID:
16959787
8.

Interaction between interleukin-10 (IL-10) polymorphisms and dietary fibre in relation to risk of colorectal cancer in a Danish case-cohort study.

Andersen V, Egeberg R, Tjønneland A, Vogel U.

BMC Cancer. 2012 May 17;12:183. doi: 10.1186/1471-2407-12-183.

9.

Association of NFKB1 -94ins/delATTG promoter polymorphism with susceptibility to autoimmune and inflammatory diseases: a meta-analysis.

Zou YF, Wang F, Feng XL, Tao JH, Zhu JM, Pan FM, Su H.

Tissue Antigens. 2011 Jan;77(1):9-17. doi: 10.1111/j.1399-0039.2010.01559.x. Epub 2010 Sep 6.

PMID:
21155719
10.

A large cohort study of aspirin and other nonsteroidal anti-inflammatory drugs and prostate cancer incidence.

Jacobs EJ, Rodriguez C, Mondul AM, Connell CJ, Henley SJ, Calle EE, Thun MJ.

J Natl Cancer Inst. 2005 Jul 6;97(13):975-80.

PMID:
15998950
11.

Prospective study of interaction between alcohol, NSAID use and polymorphisms in genes involved in the inflammatory response in relation to risk of colorectal cancer.

Vogel U, Christensen J, Dybdahl M, Friis S, Hansen RD, Wallin H, Nexø BA, Raaschou-Nielsen O, Andersen PS, Overvad K, Tjønneland A.

Mutat Res. 2007 Nov 1;624(1-2):88-100. Epub 2007 Apr 27.

PMID:
17544013
12.

Sequence variants of toll-like receptor 4 are associated with prostate cancer risk: results from the CAncer Prostate in Sweden Study.

Zheng SL, Augustsson-Bälter K, Chang B, Hedelin M, Li L, Adami HO, Bensen J, Li G, Johnasson JE, Turner AR, Adams TS, Meyers DA, Isaacs WB, Xu J, Grönberg H.

Cancer Res. 2004 Apr 15;64(8):2918-22.

13.

The impact of the use of aspirin and other nonsteroidal anti-inflammatory drugs on the risk of prostate cancer detection on biopsy.

Bhindi B, Margel D, Hamilton RJ, Fernandes KA, Trottier G, Hersey KM, Finelli A, Trachtenberg J, Zlotta A, Kulkarni GS, Toi A, Evans A, van der Kwast TH, Fleshner NE.

Urology. 2014 Nov;84(5):1073-80. doi: 10.1016/j.urology.2014.05.071. Epub 2014 Oct 24.

PMID:
25443907
14.

Nonsteroidal antiinflammatory drugs and decreased risk of advanced prostate cancer: modification by lymphotoxin alpha.

Liu X, Plummer SJ, Nock NL, Casey G, Witte JS.

Am J Epidemiol. 2006 Nov 15;164(10):984-9. Epub 2006 Aug 24.

PMID:
16931544
15.

Genetic polymorphisms in TP53, nonsteroidal anti-inflammatory drugs and the risk of colorectal cancer: evidence for gene-environment interaction?

Tan XL, Nieters A, Hoffmeister M, Beckmann L, Brenner H, Chang-Claude J.

Pharmacogenet Genomics. 2007 Aug;17(8):639-45.

PMID:
17622940
16.
17.

Interactions between diet, lifestyle and IL10, IL1B, and PTGS2/COX-2 gene polymorphisms in relation to risk of colorectal cancer in a prospective Danish case-cohort study.

Andersen V, Holst R, Kopp TI, Tjønneland A, Vogel U.

PLoS One. 2013 Oct 23;8(10):e78366. doi: 10.1371/journal.pone.0078366. eCollection 2013.

18.

Association of HPC2/ELAC2 polymorphisms with risk of prostate cancer in a population-based study.

Stanford JL, Sabacan LP, Noonan EA, Iwasaki L, Shu J, Feng Z, Ostrander EA.

Cancer Epidemiol Biomarkers Prev. 2003 Sep;12(9):876-81.

19.

Use of aspirin, but not other non-steroidal anti-inflammatory drugs is associated with decreased prostate cancer risk at the population level.

Veitonmäki T, Tammela TL, Auvinen A, Murtola TJ.

Eur J Cancer. 2013 Mar;49(4):938-45. doi: 10.1016/j.ejca.2012.09.030. Epub 2012 Oct 15.

PMID:
23079475
20.

Nonsteroidal anti-inflammatory drugs and risk of prostate cancer in the Baltimore Longitudinal Study of Aging.

Platz EA, Rohrmann S, Pearson JD, Corrada MM, Watson DJ, De Marzo AM, Landis PK, Metter EJ, Carter HB.

Cancer Epidemiol Biomarkers Prev. 2005 Feb;14(2):390-6.

Supplemental Content

Support Center